SGO recognizes gynecologic cancer clinicians, researchers at Annual Meeting on Women’s Cancer
Ellen J. Sullivan, MS, MSJ
Chief Communications and Advocacy Officer
Society of Gynecologic Oncology
NEW ORLEANS, LA (March 24, 2018)— The Society of Gynecologic Oncology (SGO) today recognized excellence in gynecologic cancer research and treatment with the presentation of several awards during the Society’s 49th Annual Meeting on Women’s Cancer in New Orleans, March 24 – 27, 2018. SGO’s awards will be presented on Saturday, March 24, during the Opening Scientific Plenary Session.
Carolyn Runowicz, MD, from Florida International University, in Miami, FL, received the Distinguished Service Award, which recognizes individuals who, over an extended period of time, display a continuous outstanding meritorious service in the field of gynecologic oncology. Dr. Runowicz became the first female president of SGO in 2000.
Kathleen Gavin, Executive Director of the Minnesota Ovarian Cancer Alliance (MOCA) in Minneapolis, MN, received the Gynecologic Oncology Humanitarian and Volunteerism Award, which is awarded to an individual for their exemplary local, national or international volunteer and outreach efforts in women’s cancer care, research or training. Ms. Gavin has been the executive director of MOCA since 2002 when she became its first staff person.
The Harry Long Award recognizes outstanding SGO Members for their contributions to multidisciplinary mentorship, collegiality or teaching in the field of gynecologic oncology. This year, SGO acknowledged two recipients: Paul Goodfellow, PhD, a professor in the Molecular Biology and Cancer Genetics Research Program at the Ohio State University in Columbus, OH, and Wui-Jin Koh, MD, a radiation oncologist from the University of Washington in Seattle.
The Innovation Award honors individuals who have been exceptionally creative thinkers who significantly impacted the understanding of and/or approaches to the prevention, diagnosis or treatment of gynecologic cancers. This year, SGO acknowledged: Ian Frazer, MD, BSc, MBBS, from the Translational Research Institute (TRI) in Brisbane, Australia. Dr. Frazer is the founding Chief Executive Officer and Director of Research for the TRI.
For the 2018 SGO Presidential Abstract Award, lead author Brian Slomovitz, MD, from the University of Miami Sylvester Comprehensive Cancer Center in Miami, FL, received the award for “GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study.”
The Society of Gynecologic Oncology (SGO) is a 501(c) (6) national medical specialty organization of physicians and allied health care professionals who are trained in the comprehensive management of women with malignancies of the reproductive tract. www.sgo.org